BDX — Bearish (ASignal Rank 4/4)
ASignal's 10+ AI agent pipeline rates BDX as Bearish with 73% confidence in the Healthcare sector.
AI Analysis Summary
Strong bearish case for BDX due to extreme leverage, deteriorating fundamentals, and negative price forecast despite short-term oversold conditions.
Investment Framework Assessment
Evaluated through three legendary investor frameworks:
- Warren Buffett (Value Investing): Grade F — 25/100
- Bill Ackman (Activist Investing): Grade B — 71/100
- Ray Dalio (Macro/Risk Parity): Grade D — 45/100
Consensus: Bearish
Price Intelligence
- Current price: $148.42
- Price target: $146.64 (-1.2%)
- Risk level: high
- Horizon: medium term
Quality Assessment
- Balance sheet: concerning
- Cash flow: good
- Competitive moat: none
Peer Group Analysis
BDX is in the “Oversold & Compressed” cluster alongside ZBH, XOM, WFC, WDAY, VLO (128 stocks total). 0 of 128 peers are currently bullish.